References
- Jones R L, Peterson C M. Hematologic alterations in diabetes mcllitus. Am J Med 1981; 70: 339–52
- Haft J I, Fani K. Stress and the induction of intravascular platelet aggregation in the heart. Circulation 1973; 48: 164–9
- Gurewich V, Lipinska I, Lipinski B. Exercise-induced fibrinolytic activity and its effect on the degradation of fibrinogen, fibrin and fibrin-like precipitates. Thromb Res 1974; 5: 647–56
- Viinikka L, Ylykorkala O. Measurement of thromboxane B2 in human plasma or serum by radioimmunoassay. Prostaglandins 1980; 20: 759–66
- Ludlam C A, Cash J D. Studies on the liberation of beta-thromboglobulin from human platelets in vitro. Br J Haem 1976; 33: 239–47
- Nossel H L, Yudelman Y, Caufield R E, et al. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43–53
- Vicari A M, Margonato A, Pctrelli P., Vicedomini G, Pozza G. Plasma beta-thromboglobulin concentration at rest and after physical exercise in complicated and uncomplicated diabetes mcllitus. Diabete et Metaholisme 1984; 10: 235–7
- Burrows A W, Chavin S I, Hockaday T DR. Plasmathromboglobulin concentrations in diabetes mellitus. Lancet 1978; i: 235–37
- Ziboh V A., Maruta H., Lord J., Cagle W D, Lucky W. Increased biosynthesis of thromboxane A2 by diabetic patients. Eur J Clin Invest 1979; 9: 223–6
- Jones R L. Fibrinopeptide A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance and hemodynamic changes. Diabetes 1985; 34: 836–49
- Gerrard J M, Stuart M J, Rao G HR. Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med 1980; 95: 950–5
- Landgraf-Leurs M MC, Landgraf R, Loy A, Weber P C, Herberg L L. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats: an animal model for type I diabetes. Prostaglandins 1982; 24: 35–46
- Winocour P D, Lopes-Virella M, Laimins M, Colwell J A. Time course of changes of in vitro platelet function and von Willebrand factor activity (VIIIR:vWF) and Factor VHI-related antigen (VIIIR:Ag) in the diabetic rat. J Lab Clin Med 1983; 102: 795–800
- Ross R, Glomset J A. The pathogenesis of atherosclerosis. N Engl J Med 1975; 295: 420–4
- Morita I, Takahashi R, Ito H, Orima H, Murota S. Increased arachidonic acid content in platelet phospholipids from diabetic patients. Prost Leuk Med 1983; 11: 33–8
- Le Pape A, Gutman N, Guitton J D, Lcgrand Y, Muh J P. Non enzymatic glycosylation increases platelet aggregating potency of collagen from placenta of diabetic human beings. Bioch Biophys ResComm 1983; 111: 602–10
- Bcnsoussan D, Levy-Toledano S, Passa P, Caen J, Canivet J. Platelet hypcraggrcgation and increased plasma level of von Willebrand factor in diabetes with retinopathy. Diabctologia 1975; 11: 307–10
- Colwell J A, van Zile J, Kilpatrick J M, Nair R MG, Virella G. Plasma factors and platelet aggregation in diabetes mellitus. Horm Met Res 1981; 11(Suppl. 1)1–6
- Mustard J F, Packham M A. Editorial retrospective. Platelets and diabetes mellitus. N Engl J Med 1984; 311: 665–67